Start for free
Start for free
Japan Asia Investment logo

Japan Asia Investment

Asia, Tokyo, Japan, Tokyo

Description

Japan Asia Investment is a venture capital firm that focuses on supporting venture companies and small and medium-sized enterprises.

Investor Profile

Japan Asia Investment has made 21 investments, with 0 in the past 12 months and 5% as lead.

Stage Focus

  • Series B (48%)
  • Series C (29%)
  • Seed (5%)
  • Series Unknown (5%)
  • Series F (5%)
  • Series D (5%)
  • Series A (5%)

Country Focus

  • United States (67%)
  • Japan (29%)
  • China (5%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Health Diagnostics
  • Manufacturing
  • Hardware
  • Health Care
  • Medical
  • Data Storage
  • Electronics
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Japan Asia Investment frequently co-invest with?

HBM Healthcare Investments
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 3
CSK Venture Capital
CSK Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Rock Creek Capital
Rock Creek Capital
North America, Florida, United States, Jacksonville
Co-Investments: 2
JAFCO Asia
JAFCO Asia
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
NS
NIF SMBC Ventures
North America, California, United States, Palo Alto
Co-Investments: 3
Yasuda Enterprise Development
Yasuda Enterprise Development
Asia, Tokyo, Japan, Tokyo
Co-Investments: 5
TDK Corporation
TDK Corporation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
FM
Frantz Medical
North America, Ohio, United States, Mentor
Co-Investments: 2
MF
MedFocus Fund
North America, California, United States, Irvine
Co-Investments: 2
Signal Lake
Signal Lake
North America, Connecticut, United States, Westport
Co-Investments: 2

What are some of recent deals done by Japan Asia Investment?

Laxus Technologies

Tokyo, Tokyo, Japan

Laxus Technologies operates the brand bag rental unlimited subscription app.

E-CommerceFashionRentalVacation Rental
Series BJan 25, 2017
Amount Raised: $12,359,248
REGiMMUNE

Tokyo, Tokyo, Japan

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

BiopharmaBiotechnologyHealth Diagnostics
Series DFeb 14, 2014
Amount Raised: $9,200,000
BioAmber

Plymouth, Minnesota, United States

BioAmber is a sustainable chemicals firm combining biotechnology and chemical catalysis to convert renewable feedstock into chemicals.

BiotechnologyChemicalGreenTech
Series AJan 17, 2010
Amount Raised: $12,000,000
Analogix Semiconductor

Santa Clara, California, United States

Analogix Semiconductor designs and manufactures high-performance analog and mixed-signal semiconductors for the digital media market.

Digital MediaElectronicsHardwareManufacturingSemiconductor
Series BAug 17, 2009
Amount Raised: $10,000,000
Chiral Quest

Monmouth Junction, New Jersey, United States

Chiral Quest uses the most economic and environmental friendly methods to produce chiral pharmaceutical intermediates and API’s.

CleanTechManufacturingPharmaceutical
Series BJan 16, 2009
Amount Raised: $13,000,000
Palo Alto Networks

Santa Clara, California, United States

Palo Alto Networks is a cybersecurity company that offers cybersecurity solutions for organizations.

Cloud SecurityCyber SecurityNetwork SecuritySecurity
Series CNov 3, 2008
Amount Raised: $10,000,000
REGiMMUNE

Tokyo, Tokyo, Japan

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

BiopharmaBiotechnologyHealth Diagnostics
Series BMay 6, 2008
Amount Raised: $8,000,000
Chestnut Medical

Menlo Park, California, United States

Chestnut Medical offers minimally invasive therapies to improve outcomes and reduce complications of neurovascular disease treatments.

Health Care
Series CMar 15, 2008
Amount Raised: $7,800,000
REGiMMUNE

Tokyo, Tokyo, Japan

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

BiopharmaBiotechnologyHealth Diagnostics
Series BFeb 1, 2008
Amount Raised: $6,000,000
Ecrio

Cupertino, California, United States

Ecrio develops a framework to upgrade common applications into communication-rich applications for multiple operating systems and phones.

Operating SystemsReal TimeSoftware
Series CSep 19, 2007
Amount Raised: $24,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator